跳至主要内容
临床试验/NCT05849987
NCT05849987尚未招募不适用

Retinitis Pigmentosa Clinical Study: Examining the Clinical Trial Journey of Retinitis Pigmentosa Patients

Power Life Sciences Inc.0 个研究点目标入组 500 人开始时间: 2024年5月最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
500
主要终点
Number of patient decides to enroll in clinical trial

研究概览

简要总结

Typically, clinical research participation favors a specific demographic group, and little research exists on how trial attributes affect participation. As such, this study seeks to analyze data from different demographic groups and check for recurring trends that could provide valuable insights for future retinitis pigmentosa patients.

研究设计

研究类型
Observational
观察模型
Case Crossover
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Is 18+ years old
  • Confirmed diagnosis of retinitis pigmentosa
  • Signed Written Informed Consent

排除标准

  • Inability to perform regular electronic reporting
  • Participant is actively receiving study therapy in another trial
  • Women of childbearing potential without a negative pregnancy test; or women who are lactating.

结局指标

主要结局

Number of patient decides to enroll in clinical trial

时间窗: 3 months

Rate of patients who remain in clinical trial to trial completion

时间窗: 12 months

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

相似试验